Institute of Physics , University of Silesia , 75 Pulku Piechoty 1A , 41-500 Chorzow , Poland.
Silesian Center for Education and Interdisciplinary Research , 75 Pulku Piechoty 1A , 41-500 Chorzow , Poland.
Mol Pharm. 2018 Jul 2;15(7):2807-2815. doi: 10.1021/acs.molpharmaceut.8b00312. Epub 2018 Jun 5.
Rational selection of polymers for amorphous drug stabilization is necessary for further successful development of solid dispersion technology. In this paper, we investigate the effect of polymer chain length on the inhibition of amorphous drug recrystallization. To consider this problem, we prepared a drug-polymer blend (in 10:1 drug to polymer ratio) containing bicalutamide (BIC) and polyvinylpyrrolidone (PVP) with different chain lengths K10, K30, and K90. We applied broadband dielectric spectroscopy to compare the molecular dynamics of investigated samples and thoroughly recognize their crystallization tendencies from supercooled liquid state. Despite the lack of differences in molecular dynamics, we noticed significant changes in their crystallization rates. To rationalize such behavior, we performed positron annihilation lifetime spectroscopy measurements. The results showed that the value of free volume was the highest for blend with PVP K90, which at the same time was characterized by the greatest tendency to crystallize. We postulate that the polymer chain, depending on its length, can have different configurations in the space, leading to better or worse sample stabilization. Our results highlight how important is detailed understanding of physical properties of polymers for judicious selection of the best stabilization approach.
理性选择聚合物以稳定非晶态药物对于进一步成功开发固体分散体技术是必要的。在本文中,我们研究了聚合物链长对抑制非晶态药物重结晶的影响。为了考虑这个问题,我们制备了含有比卡鲁胺(BIC)和聚乙烯吡咯烷酮(PVP)的药物-聚合物共混物(药物与聚合物的比例为 10:1),其中 PVP 的链长分别为 K10、K30 和 K90。我们应用宽频介电谱比较了研究样品的分子动力学,并从过冷液体状态彻底认识了它们的结晶趋势。尽管分子动力学没有差异,但我们注意到它们的结晶速率有显著变化。为了使这种行为合理化,我们进行了正电子湮没寿命谱测量。结果表明,具有 PVP K90 的共混物的自由体积值最高,同时其结晶趋势最大。我们假设,聚合物链根据其长度,可以在空间中具有不同的构型,从而导致更好或更差的样品稳定性。我们的结果强调了详细了解聚合物的物理性质对于明智选择最佳稳定化方法的重要性。